Hyaluronic acid (hyaluronan): A review
Open accessAbstract
Hyaluronic acid (HA) is a high molecular weight biopolysacharide, discovered in 1934, by Karl Meyer and his assistant, John Palmer in the vitreous of bovine eyes. Hyaluronic acid is a naturally occurring biopolymer, which has important biological functions in bacteria and higher animals including humans. It is found in most connective tissues and is particularly concentrated in synovial fluid, the vitreous fluid of the eye, umbilical cords and chicken combs. It is naturally synthesized by a class of integral membrane proteins called hyaluronan synthases, and degraded by a family of enzymes called hyaluronidases. This review describes metabolisms, different physiological and pathological functions, basic pharmacological properties, and the clinical use of hyaluronic acid.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
HA is a linear polyanionic polysaccharide that occurs naturally in all living organisms and maintains an appropriate level of tissue hydration.
“HA is a linear polyanionic polysaccharide, with the structure of glucuronic acid and N-acetylglucosamine repeating units linked via alternating β-1,4 and β-1,3 glycosidic bonds, which occurs naturally in all living organisms and maintains an appropriate level of tissue hydration [57].”
From Resorbable Biomaterials Used for 3D Scaffolds in Tissue Engineering: A Review (2023) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 32
- Akmal M., Singh A., Anand A., Kesani A., Aslam N., Goodship A., Bentley G. (2005): The effects of hy- aluronic acid on articular chondrocytes. Journal of B one and Joint Surger y -British volume, 8, 1143-1149.
- Antonas K.N., Fraser J.R.E., Muirden K.D. (1973): Dis- tribution of biologically labelled hyaluronic acid in- jected into joints. Annals of Rheumatic Diseases, 32, 103-111.
- Balazs E.A., Denlinger J.L. (1984): The role of hyaluronic acid in arthritis and its therapeutic use. In: Peyron J.G. (ed.): Osteoarthritis: Current Clinical and Fundamen- tal Problems. Geigy, Basle Geigy. 165-174.
- Balazs E.A., Denlinger J.L (1989): Clinical uses of hy- aluronan. Ciba Found Symposium, 143, 265-275.
- Balazs E.A., Laurent T.C., Jeanloz R.W. (1986): Nomencla- ture of hyaluronic acid. Biochemical Journal, 235, 903.
- Banerji S., Ni J., Wang S.X., Clasper S., Su J., Tammi R., Jones M., Jackson D.G. (1999): LYVE-1, a new homo- logue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. The Journal of Cell Biology, 4, 789-801.
- Bentsen K.D., Henriksen J.H., Boesby S., Horstev-Pe- tersen K., Lorenzen I. (1989): Hepatic and renal excre- tion of circulating type III procollagen amino-terminal propeptide and hyaluronan in pig. Journal of Hepatol- ogy, 9, 177-183.
- Brown M.B., Jones S.A. (2005): Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. Journal of European Academy of Dermatol- ogy and Venereology, 19, 308-318.
- Camenisch T.D., Spicer A.P., Brehm-Gibson T., Biester- feldt J., Augustine M.L., Calabro A. Jr., Kubalak S., Klewer S.E., McDonald J.A. (2000): Disruption of hy- aluronan synthase-2 abrogates normal cardiac mor- phogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. Journal of Clinical In- vestigation, 106, 349-360.
- Echigo R., Mochizuki M., Nishimura R., Sasaki N. (2006): Suppressive effect of hyaluronan on chondrocyte ap- optosis in experiment induced acute osteoarthritis in dog. Journal of Veterinary Medical Sciences, 68, 899-902.
- Fraser J.R.E., Laurent T.C., Pertoft H., Baxter E. (1981): Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochemical Journal, 200, 415-424.
- Hajjaji H.E., Cole A.A., Manicourt D.H. (2005): Chon- drocytes, synoviocytes and dermal fibroblasts all ex- press PH-20, a hyaluronidase active at neutral pH. Arthritis Research and Therapy, 7, R756-R768.
- Hill A., McFarlane S., Johnston P.G., Waugh D.J.J. (2006): The emerging role of CD44 in regulating skeletal mi- crometastasis. Cancer Letters, 237, 1-9.
- Karjalainen J.M., Tammi R.H., Tammi M.I., Eskelinen M.J., Agren U.M., Parkkinen J.J., Alhava E.M., Kosma V.M. (2000): Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. American Journal of Pathol- ogy, 157, 957-965.
- Kim C.H., Lee B.J., Yoon J., Seo K.M., Lee J.W., Choi E.S., Hong J.J., Lee Y.S., Park J.H. (2001): Therapeutic effect of hyaluronic acid on experimental osteoarthrosis of ovine temporomandibular joint. Journal of Veterinary Medical Sciences, 63, 1083-1089.
- Kim E., Baba D., Kimura M., Yamashita M., Kashiwabara S., Baba T. (2005): Identification of a hyaluronidase, Hyal5, involved in penetration of mouse sperm through cumulus mass. Proceedings of the National Academy of Sciences of the United States of America, 50, 18028-18033.
- Laurent T.C. (1989): The biology of hyaluronan. In: Ciba Foundation Symposium 143. John Wiley and Sons, New York. 1-298.
- Laurent T.C., Fraser J.R.E. (1992): Hyaluronan. FASEB Journal, 6, 2397-2404.
- Lin G., Stern R. (2001): Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling. Cancer Letters, 163, 95-101.
- Lokeshwar V.B., Schroeder G.L., Carey R.I., Soloway M.S., Iida N. (2002): Regulation of hyaluronidase activ- ity by alternative mRNA splicing. Journal of Biological Chemistry, 277, 33654-33663.
- McKee C.M., Penno M.B., Cowman M., Burdick M.D., Strieter R.M., Bao C., Noble P.W. (1996): Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. Journal of Clinical Investigation, 98, 2403-2413.
- Medina J.M., Thomas A., Denegar C.R. (2006): Knee os- teoarthritis: Should your patient opt for hyaluronic acid injection? Journal of Family Practice, 8, 667-675.
- Meyer K., Palmer J.W. (1934): The polysaccharide of the vitreous humor. Journal of Biology and Chemistry, 107, 629-634.
- Neo H., Ishimaru J.I., Kurita K., Goss A.N. (1997): The effect of hyaluronic acid on experimental temporo- mandibular joint osteoarthrosis in the sheep. Journal of Oral Maxillofacial Surgery, 55, 1114-1119.
- Protin U., Schweighoffer T., Jochum W., Hilberg F. (1999): CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte sub- sets1. The Journal of Immunology, 163, 4917-4923.
- Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., Gallo R.L. (2004): Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. Journal of Biolog ical Chemistr y, 279, 17079-17084.
- Toole B.P. (1997): Hyaluronan in morphogenesis. Journal of Internal Medicine, 242, 35-40.
- Turley E.A., Noble P.W., W. Bourguignon L.Y. (2002): Signaling properties of hyaluronan receptors. Journal of Biological Chemistry, 277, 4589-4592.
- Tzircotis G., Thorne R.F., Isacke C.M. (2005): Chemo- taxis towards hyaluronan is dependent on CD44 ex- pression and modulated by cell type variation in CD44-hyaluronan binding. Journal of Cell Science, 118, 5119-5128.
- Underhill C. (1992): CD44: The hyaluronan receptor. Journal of Cell Sciences, 103, 293-298.
- Uthman I., Raynauld J.P., Haraoui B. (2003): Intra-artic- ular therapy in osteoarthritis. Postgradual Medicine Journal, 79, 449-453.
- Wang C.T., Lin J., Chang C.J., Lin Y.T., Hon S.M. (2004): Therapeutics effects of hyaluronic acid on osteoar- thritis of the knee. The Journal of Bone and Joint Sur- gery -American Volume, 3, 538-545.
Cited by
Sorted by citations
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine
Mattheolabakis, G., Milane, L., Singh, A., & Amiji, M. M. (2015) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1052072 · Cited by 597 · see citing works
Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA Delivery
Ho, W., Gao, M., Li, F., Li, Z., Zhang, X., & Xu, X. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001812 · Cited by 261 · see citing works
Divergent immune responses to synthetic and biological scaffolds
Sadtler, K., Wolf, M. T., Ganguly, S., Moad, C. A., Chung, L., Majumdar, S., Housseau, F., Pardoll, D. M., & Elisseeff, J. H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.002 · Cited by 256 · see citing works
Costa, E. C., de Melo‐Diogo, D., Moreira, A. F., Carvalho, M. P., & Correia, I. J. (2018) · Biotechnology Journal · doi:10.1002/biot.201700417 · Cited by 224 · see citing works
Emerging materials for hemostasis
Li, X.-F., Lu, P., Jia, H.-R., Li, G., Zhu, B., Wang, X., & Wu, F.-G. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214823 · Cited by 164 · see citing works
Resorbable Biomaterials Used for 3D Scaffolds in Tissue Engineering: A Review
Vach Agocsova, S., Culenova, M., Birova, I., Omanikova, L., Moncmanova, B., Danisovic, L., Ziaran, S., Bakos, D., & Alexy, P. (2023) · Materials · doi:10.3390/ma16124267 · Cited by 98 · see citing works
Mun, J., Mok, J. W., Jeong, S., Cho, S., Joo, C.-K., & Hahn, S. K. (2019) · RSC Advances · doi:10.1039/c9ra02858g · Cited by 82 · see citing works
Non-viral strategies for ocular gene delivery
Oliveira, A. V., Rosa da Costa, A. M., & Silva, G. A. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.04.068 · Cited by 80 · see citing works
Fayad, S., Nehmé, R., Tannoury, M., Lesellier, E., Pichon, C., & Morin, P. (2017) · Journal of Chromatography A · doi:10.1016/j.chroma.2017.03.033 · Cited by 54 · see citing works
Göllner, I., Voss, W., von Hehn, U., & Kammerer, S. (2017) · Journal of Evidence-Based Complementary & Alternative Medicine · doi:10.1177/2156587217743640 · Cited by 54 · see citing works
Carbohydrate Immune Adjuvants in Subunit Vaccines
Bashiri, S., Koirala, P., Toth, I., & Skwarczynski, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100965 · Cited by 45 · see citing works
How to Fight Acute Sun Damage? Current Skin Care Strategies
Jesus, A., Sousa, E., Cidade, H., Cruz, M. T., & Almeida, I. F. (2024) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-024-00641-3 · Cited by 3 · see citing works
- Authors
- Necas, J., Bartosikova, L., Brauner, P., & Kolar, J.
- Affiliations
- University of Veterinary Sciences Brno (CZ)
- Venue
- Veterinární medicína
- Published
- 2008-08-31
- Volume
- 53
- Issue
- 8
- Pages
- 397-411
- ISSN
- 0375-8427 (ISSN-L)
- 1805-9392
- OpenAlex
- W2099935411
- Cited by
- 998
- References
- 0
- Citations by year
- 2026: 45 · 2025: 68 · 2024: 78 · 2023: 68 · 2022: 100 · 2021: 94 · 2020: 94 · 2019: 100 · 2018: 73 · 2017: 72 · 2016: 60 · 2015: 53 · 2014: 48 · 2013: 23 · 2012: 15
- FWCI
- 0.19
- Type
- journal article
- Language
- cs
- Open access
- gold
- doi.org
- Licence
- Locations
- Veterinární Medicína (publishedVersion, cc-by-nc)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Hydrogels: synthesis, properties, applications
- Keywords
- hyaluronic acid, hyaluronan synthase, hyaluronidase, hyaluronic acid metabolism, connective tissue, synovial fluid, vitreous humor, clinical application, pathological functions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review